These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16766608)

  • 1. CFTR: Ligand exchange between a permeant anion ([Au(CN)2]-) and an engineered cysteine (T338C) blocks the pore.
    Serrano JR; Liu X; Borg ER; Alexander CS; Shaw CF; Dawson DC
    Biophys J; 2006 Sep; 91(5):1737-48. PubMed ID: 16766608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFTR: a cysteine at position 338 in TM6 senses a positive electrostatic potential in the pore.
    Liu X; Zhang ZR; Fuller MD; Billingsley J; McCarty NA; Dawson DC
    Biophys J; 2004 Dec; 87(6):3826-41. PubMed ID: 15361410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular determinants of Au(CN)(2)(-) binding and permeability within the cystic fibrosis transmembrane conductance regulator Cl(-) channel pore.
    Gong X; Burbridge SM; Cowley EA; Linsdell P
    J Physiol; 2002 Apr; 540(Pt 1):39-47. PubMed ID: 11927667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupled movement of permeant and blocking ions in the CFTR chloride channel pore.
    Gong X; Linsdell P
    J Physiol; 2003 Jun; 549(Pt 2):375-85. PubMed ID: 12679371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the origin of asymmetric interactions between permeant anions and the cystic fibrosis transmembrane conductance regulator chloride channel pore.
    Fatehi M; St Aubin CN; Linsdell P
    Biophys J; 2007 Feb; 92(4):1241-53. PubMed ID: 17142267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants and role of an anion binding site in the external mouth of the CFTR chloride channel pore.
    Gong X; Linsdell P
    J Physiol; 2003 Jun; 549(Pt 2):387-97. PubMed ID: 12679372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple inhibitory effects of Au(CN)(2-) ions on cystic fibrosis transmembrane conductance regulator Cl(-) channel currents.
    Linsdell P; Gong X
    J Physiol; 2002 Apr; 540(Pt 1):29-38. PubMed ID: 11927666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFTR: covalent modification of cysteine-substituted channels expressed in Xenopus oocytes shows that activation is due to the opening of channels resident in the plasma membrane.
    Liu X; Smith SS; Sun F; Dawson DC
    J Gen Physiol; 2001 Oct; 118(4):433-46. PubMed ID: 11585853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable reactivity of an engineered cysteine at position 338 in cystic fibrosis transmembrane conductance regulator reflects different chemical states of the thiol.
    Liu X; Alexander C; Serrano J; Borg E; Dawson DC
    J Biol Chem; 2006 Mar; 281(12):8275-85. PubMed ID: 16436375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic fibrosis transmembrane conductance regulator: using differential reactivity toward channel-permeant and channel-impermeant thiol-reactive probes to test a molecular model for the pore.
    Alexander C; Ivetac A; Liu X; Norimatsu Y; Serrano JR; Landstrom A; Sansom M; Dawson DC
    Biochemistry; 2009 Oct; 48(42):10078-88. PubMed ID: 19754156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible role for intracellular GSH in spontaneous reaction of a cysteine (T338C) engineered into the Cystic Fibrosis Transmembrane Conductance Regulator.
    Liu X
    Biometals; 2008 Jun; 21(3):277-87. PubMed ID: 17849169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis transmembrane conductance regulator: temperature-dependent cysteine reactivity suggests different stable conformers of the conduction pathway.
    Liu X; Dawson DC
    Biochemistry; 2011 Nov; 50(47):10311-7. PubMed ID: 22014307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in accessibility of cytoplasmic substances to the pore associated with activation of the cystic fibrosis transmembrane conductance regulator chloride channel.
    El Hiani Y; Linsdell P
    J Biol Chem; 2010 Oct; 285(42):32126-40. PubMed ID: 20675380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fifth Transmembrane Segment of Cystic Fibrosis Transmembrane Conductance Regulator Contributes to Its Anion Permeation Pathway.
    Zhang J; Hwang TC
    Biochemistry; 2015 Jun; 54(24):3839-50. PubMed ID: 26024338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular cysteines of the cystic fibrosis transmembrane conductance regulator (CFTR) modulate channel gating.
    Ketchum CJ; Yue H; Alessi KA; Devidas S; Guggino WB; Maloney PC
    Cell Physiol Biochem; 2002; 12(1):1-8. PubMed ID: 11914543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CFTR: covalent and noncovalent modification suggests a role for fixed charges in anion conduction.
    Smith SS; Liu X; Zhang ZR; Sun F; Kriewall TE; McCarty NA; Dawson DC
    J Gen Physiol; 2001 Oct; 118(4):407-31. PubMed ID: 11585852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localizing a gate in CFTR.
    Gao X; Hwang TC
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2461-6. PubMed ID: 25675504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis transmembrane conductance regulator (CFTR) anion binding as a probe of the pore.
    Mansoura MK; Smith SS; Choi AD; Richards NW; Strong TV; Drumm ML; Collins FS; Dawson DC
    Biophys J; 1998 Mar; 74(3):1320-32. PubMed ID: 9512029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-dependent access of anions to the cystic fibrosis transmembrane conductance regulator chloride channel pore.
    Fatehi M; Linsdell P
    J Biol Chem; 2008 Mar; 283(10):6102-9. PubMed ID: 18167343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between impermeant blocking ions in the cystic fibrosis transmembrane conductance regulator chloride channel pore: evidence for anion-induced conformational changes.
    Ge N; Linsdell P
    J Membr Biol; 2006 Mar; 210(1):31-42. PubMed ID: 16794779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.